Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled date : 2021 - 08 - 03 save search
111, Inc. Enters into Strategic Cooperation Agreement with Zelgen to Develop a New Management Platform for Liver Cancer Patients in China
Published: 2021-08-03 (Crawled : 21:00) - biospace.com/
YI | $1.02 2.0% 1.96% 9.3K
|
Retail Trade
|
| O: -0.49%
H: 7.83%
C: 5.38%
china cancer liver
LIXTE BIOTECHNOLOGY’S LB-100 ELICITS ANTI- TUMOR ACTIVITY IN SMALL LUNG CANCER MODELS BY UNIQUE MECHANISMS IN AN IMPORTANT PRE-CLINICAL STUDY
Published: 2021-08-03 (Crawled : 14:00) - globenewswire.com
LIXT | $3.351 4.68% 11K
|
Health Technology
|
| O: 18.15%
H: 24.54%
C: -14.76%
lung cancer unique pre-clinical cancer biotech technology iot preclinical
Increasing Adoption of Targeted Cancer Therapies to Propel Oncolytic Virus Immunotherapy Market, Says TMR
Published: 2021-08-03 (Crawled : 13:15) - prnewswire.com
SRNE | $0.024 -8.85% 57K
|
Health Technology
|
| O: -0.48%
H: 0.72%
C: -1.33%
REPL | $6.47 -7.17% -7.73% 870K
|
Health Technology
|
| O: 0.84%
H: 3.45%
C: 1.78%
ONCR | $0.126 -75.95% 140K
|
Health Technology
|
| O: -0.24%
H: 1.98%
C: -1.74%
immunotherapy therapy cancer
Predictive Oncology subsidiary, Helomics uses data from the 100,000 Genomes Project to better predict ovarian cancer outcomes
Published: 2021-08-03 (Crawled : 13:00) - globenewswire.com
POAI | $1.2 4.34% 4.16% 49K
|
Health Technology
|
| O: 0.96%
H: 1.65%
C: -1.82%
ORGS | $0.5001 -2.34% -2.4% 60K
|
Health Technology
|
| O: -0.6%
H: 0.8%
C: 0.4%
cancer ovarian cancer
Tachyon and AbCellera Collaborate to Develop Novel Antibody Therapeutic Targeting TGF-β Superfamily Member for the Treatment of Cancer
Published: 2021-08-03 (Crawled : 11:00) - biospace.com/
ABCL | $3.88 -0.77% -0.77% 980K
|
|
| O: 1.14%
H: 0.0%
C: -1.56%
treatment cancer antibody collaboration
SpringWorks Therapeutics Announces Phase 1b/2a Clinical Trial of Mirdametinib in Patients with Advanced Solid Cancers Harboring MAPK-Activating Mutations
Published: 2021-08-03 (Crawled : 11:00) - globenewswire.com
SWTX | $40.075 -5.64% -5.98% 1.4M
|
Health Technology
|
| O: 0.15%
H: 1.09%
C: 0.21%
phase 1 cancer trial phase 1b phase 2b
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.